CL Colgate-Palmolive

Q3 2025 10-Q

Filed: Oct 31, 2025Period ending Sep 30, 2025

Health Care

Perfumes, Cosmetics & Other Toilet PreparationsSEC EDGAR

Colgate-Palmolive (CL) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 31, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Section 'mda' was empty or not found.

Risk Factors

• No new or changed risk factors reported in this 10-Q versus 2024 10-K
• Continued exposure to supply chain disruptions impacting raw materials and production costs

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$5.1B

▲ +2.0% YoY▲ +0.4% QoQ

Net Income

$736M

▼ 0.0% YoY▼ -0.9% QoQ

Gross Margin

59.4%

▼ -167bp YoY▼ -64bp QoQ

Operating Margin

20.6%

▼ -56bp YoY▼ -52bp QoQ

Net Margin

14.3%

▼ -28bp YoY▼ -20bp QoQ

ROE

86.0%

Total Assets

$17.5B

EPS (Diluted)

$0.91

▲ +1.1% YoY▼ 0.0% QoQ

Operating Cash Flow

$1.3B

▲ +8.1% YoY▲ +42.6% QoQ

Source: XBRL data from Colgate-Palmolive Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Colgate-Palmolive Quarterly Reports

Q1 2025 10-Q

Get deeper insights on Colgate-Palmolive

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.